2021-11-16-世界卫生组织-Cervical_cancer_Peru_2021_country_profile_1页_65kb

PERU CERVICAL CANCER PROFILE SUMMARY

Morbidity and Mortality

• Crude cervical cancer incidence: 25.7 per 100,000 women (2020).
• Age-standardized incidence: 22.2 per 100,000 women (2020).
• Cumulative risk: 2.3% ages 0-74 (2020).
• Deaths: 1,900 (2019).
• Mortality-to-incidence ratio: 0.54 (2020).
• Population-based cancer registry exists (2021).

Primary Prevention

• HPV vaccination coverage: 74% among girls, introduced in 2015; final dose coverage 7% (2020).
• HIV incidence: 0.07 per 1,000 women aged 15+ years (2020).
• Other factors: Tobacco use prevalence 3% (2020); condom use 18% (2000).

Secondary Prevention

• National cervical cancer screening program exists (2021), using cytology; target age 30-49 years.
• Ever screened rate: 89%; 75% screened in last 5 years.
• Referral systems and early detection guidelines in place (2021).

Treatment and Supportive Care

• National guidelines for management exist (2021).
• Cancer diagnosis and treatment services generally available, with specific facilities like radiotherapy units and oncologists.
• Palliative care accessible for non-communicable diseases.

WHO Elimination Strategy

• Targets for cervical cancer elimination by 2030 in place.

Key Statistics

• Total female population: 16,360,000 (2019).
• Female deaths: 67,400 (2019).